Recurrent Implantation Failure: Where Does the Endometrial Microbiome Actually Fit?

After several failed embryo transfers, should microbiome testing automatically be your next step?

Not necessarily.

When an embryo transfer doesn't result in pregnancy, patients naturally want to know why.

After several unsuccessful transfers, that question can become even more urgent:

What are we missing?

And with increasing attention being given to the endometrial microbiome, it's understandable that patients may wonder whether bacteria inside the uterus could be responsible.

But recurrent implantation failure is complicated—and the microbiome is only one piece of a much larger puzzle.

New guidance from the American Society for Reproductive Medicine (ASRM) helps put this into perspective.

What Is Recurrent Implantation Failure?

Even the definition of recurrent implantation failure, or RIF, has been inconsistent in medical research.

In its 2026 committee opinion, ASRM recommends defining RIF based on the failure of enough good-quality blastocysts to reach an estimated 95% cumulative chance of a positive pregnancy test.

Current evidence suggests this may occur after approximately 3–6 failed transfers of euploid embryos, while the number of untested embryos needed to meet the definition depends partly on age. ASRM also notes limitations in the data behind these estimates.

That distinction matters.

One or two unsuccessful embryo transfers do not automatically mean that something is wrong with the endometrium—or that a patient has RIF.

Before Looking at the Microbiome, Look at the Bigger Picture

Implantation depends on many factors.

The embryo itself is critically important. Chromosomal abnormalities are a major reason embryos fail to implant or continue developing.

The uterine environment matters too.

For patients who meet criteria for RIF, ASRM says it can be reasonable to reassess the uterus and fallopian tubes with tools such as saline sonography, hysteroscopy, HSG or 3D ultrasound.

Depending on the individual patient's history, physicians may also consider issues such as polyps, fibroids, hydrosalpinx, adenomyosis, endometriosis and other clinical factors.

So before jumping to a specialized test, an important question is:

Have the more established potential causes been adequately evaluated?

Where Does the Endometrial Microbiome Fit?

This is where the research gets interesting.

Scientists now recognize that microorganisms can be detected in the reproductive tract, and researchers have found associations between certain microbial patterns and reproductive outcomes.

Some studies have reported poorer implantation and pregnancy outcomes when the endometrial microbiome was not dominated by Lactobacillus species.

Research has also identified differences in vaginal microbial patterns among some patients experiencing RIF.

But there's a very important distinction:

An association does not prove causation.

Finding a different microbial pattern in patients who experience implantation failure does not necessarily mean that the bacteria caused the failure.

And it does not automatically mean that changing those bacteria will improve the chance of having a baby.

ASRM's 2026 guidance reflects that uncertainty: current data suggest that the uterine microbiome may be associated with implantation, but further research is needed to determine whether screening and treatment should be used for patients with RIF.

What About Chronic Endometritis?

This is another important distinction.

As we discussed in Post 16, chronic endometritis and an altered endometrial microbiome are not the same diagnosis.

Chronic endometritis is persistent inflammation of the uterine lining and can be evaluated through endometrial biopsy, although even here there is no universally agreed-upon diagnostic threshold.

ASRM reports that some observational studies support considering testing and/or antibiotic treatment for chronic endometritis in patients with RIF.

However, the evidence remains inconclusive, and better randomized controlled trials are needed to determine the best diagnostic and treatment strategy.

So again:

Finding bacteria is not automatically the same as diagnosing chronic endometritis.

More Testing Isn't Always Better

This may be one of the most important messages for IVF patients.

After repeated failed transfers, it is tempting to search for every possible explanation.

More tests can feel like more answers.

But sometimes they create more uncertainty rather than more clarity.

ASRM currently finds insufficient evidence to support the routine use of several commonly discussed interventions or tests in RIF, including routine endometrial receptivity analysis (ERA), and it does not recommend endometrial scratching. Evidence is also insufficient for routine immunologic therapies in RIF.

Most importantly, ASRM advises that when a careful evaluation does not identify a clear, correctable cause, extensive additional testing may not be necessary. Continuing with embryo transfer can be reasonable, and many patients ultimately do achieve pregnancy.

Questions to Ask Before Microbiome Testing

If microbiome testing is being considered after unsuccessful embryo transfers, try asking your fertility specialist:

“What exactly are we looking for?”

“Is there evidence that this test could identify something that changes my treatment?”

“Are we evaluating for chronic endometritis, the microbiome, or both?”

And perhaps the most important question:

“If the result is abnormal, do we know that treating it improves IVF outcomes?”

Those questions can turn a confusing test result into a much more useful conversation.

The Bottom Line

The endometrial microbiome is an exciting area of reproductive research.

It may eventually help us better understand why implantation succeeds in some circumstances and fails in others.

But we're not there yet.

For patients experiencing repeated failed embryo transfers:

The microbiome may be part of the investigation—but it shouldn't automatically become the explanation.

Good IVF care means looking at the embryo, the uterus, the patient's individual history and the strength of the evidence before deciding what to test or treat.

And sometimes the most useful question isn't:

“What else can we test?”

It's:

“What will this test change?”

That is a question worth asking.

This article is for educational purposes only and is not intended to diagnose or treat infertility or replace advice from your fertility specialist.

IVF Monitoring LV | Evidence-Based IVF Education